Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 4/20 | 0.37 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | TACR1 | P25103 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 2/20 | 0.32 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.32 |
| ▸ | CCR5 | P51681 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.32 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3585808 | 1.00 | AKR1C3 (0.37) | AKR1C3AKR1C2MEN1KMT2AALDH1A1 | |
| SCHEMBL3602359 | 0.90 | AKR1C3 (0.37) | AKR1C3AKR1C2ALDH1A1CYP2D6SLC6A2 | |
| SCHEMBL3602364 | 0.90 | AKR1C3 (0.37) | AKR1C3AKR1C2ALDH1A1CYP2D6SLC6A2 | |
| SCHEMBL3592767 | 0.88 | CCR5 (0.36) | MEN1KMT2AALDH1A1KCNJ1CCR5 | |
| SCHEMBL3585732 | 0.87 | AKR1C3 (0.37) | AKR1C3AKR1C2MEN1KMT2AALDH1A1 | |
| SCHEMBL3585737 | 0.87 | AKR1C3 (0.37) | AKR1C3AKR1C2MEN1KMT2AALDH1A1 | |
| SCHEMBL3585504 | 0.86 | AKR1C3 (0.36) | AKR1C3AKR1C2ALDH1A1CYP2D6SLC6A2 | |
| SCHEMBL3586837 | 0.86 | AKR1C3 (0.36) | AKR1C3AKR1C2ALDH1A1CYP2D6SLC6A2 | |
| SCHEMBL3585512 | 0.86 | AKR1C3 (0.36) | AKR1C3AKR1C2ALDH1A1CYP2D6SLC6A2 | |
| SCHEMBL3586832 | 0.86 | AKR1C3 (0.36) | AKR1C3AKR1C2ALDH1A1CYP2D6SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190768-A1 | NOVEL FUSED PYROLE DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190768-A1 | NOVEL FUSED PYROLE DERIVATIVE | NR3C1, NR3C2, NR0B1 | AKR1C3 278/4885AKR1C2 614/4885MEN1 3628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.